US Patent 10927367 CBLB endonuclease variants, compositions, and methods of use
Patent 10927367 was granted and assigned to Bluebird Bio on February, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 25, 2019
Date of Patent
February 23, 2021
Patent Applicant
Patent Application Number
16694815
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10927367 CBLB endonuclease variants, compositions, and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.